Ankylosing Spondylitis PBMC
About: Ankylosing Spondylitis PBMC samples are isolated from donors with clinically confirmed ankylosing spondylitis. Ideal for studying T cell activity, HLA-B27–associated immune responses, and chronic inflammation in axial spondyloarthritis.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 77504 | Ankylosing Spondylitis | 10M | African American | 67 | Female |
Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD
|
5 | |||
| 77063 | Ankylosing Spondylitis | 10M | Caucasian | 68 | Female |
Skyrizi - 360 ml monthly Lisinopril - 0.075 daily Pantoprazole - 20 mg daily Atorvastatin - 20 mg daily Lamotrigine - 150 mg daily Seroquel - 100mg daily Trazadone - 100 mg daily
|
121 | |||
| 74686 | Ankylosing Spondylitis | 50M | Caucasian | 60 | Female |
Simponi Inf Q6W Chlorthalidone 12.5 mg QD Zepbound 10 mg QW Methimazole 5 mg QOD Rosuvastatin 5 mg QD Lefluonimide 20 mg QOD Potassium Chloride 20 mEq BID Vitamin B Vitamin D
|
124 | $1,208.00 | ||
| 72201 | Ankylosing Spondylitis | 10M | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
13 | |||
| 71615 | Ankylosing Spondylitis | 10M | Asian/Pacific Islander | 63 | Male |
Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD
|
3 | |||
| 77876 | Ankylosing Spondylitis | 5M | Caucasian | 62 | Male |
Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD
|
1 | $765.00 | ||
| 77419 | Ankylosing Spondylitis | 3M | Caucasian | 46 | Male |
Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD
|
1 | |||
| 77405 | Ankylosing Spondylitis | 10M | Hispanic/Latino | 43 | Female |
None Not taking any medications for hypertension.
|
6 | |||
| 76540 | Ankylosing Spondylitis | 10M | Caucasian | 54 | Female |
Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD
|
11 | |||
| 71399 | Ankylosing Spondylitis | 50M | Caucasian | 82 | Male | United States (US) |
Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD
|
106 | $1,208.00 |
High-Quality Ankylosing Spondylitis PBMC for Research
Ankylosing Spondylitis PBMC products are sourced from donors clinically diagnosed with Ankylosing Spondylitis and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on disease-specific immune dysregulation, T cell subsets, and cytokine production.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed Ankylosing Spondylitis donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified Ankylosing Spondylitis diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional ankylosing spondylitis-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in ankylosing spondylitis pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Ankylosing Spondylitis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.